NCT06361095

Confirmatory Efficacy Trial of Attention Bias Modification for Depression

Name: Clinical Trial NCT06361095
Creator: University of Texas at Austin
Keywords: Depression, Traditional Attention Bias Modification, Phase 1, behavioral, clinical trial, United States of America

Confirmatory Efficacy Trial of a Traditional vs. Gamified Attention Bias Modification for Depression

University of Texas at Austin·Phase 1·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Depression
Drug/Device/Intervention: Traditional Attention Bias Modification
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: University of Texas at Austin
Location: Austin, United States of America

Timeline & enrollment

Phase: Phase 1
Start date: May 01, 2024
End date: Mar 01, 2028
Enrollment: 600 participants

Primary outcome

QIDS (Quick Inventory of Depression Symptoms) SR-16

Summary

The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are:  - Aim 1:examine whether gamified ABM leads to greater change in the primary and secondary outcomes than sham ABM  - Aim 1: establish that gamified ABM is at least as effective as traditional ABM.  - Aim 2: identify moderators of ABM efficacy and mechanisms responsible for its efficacy.  - Aim 3: Identify the durability of ABM on depression symptoms during short-term follow-up  Participants will complete self-report questionnaires, complete eye-tracking tasks, and be clinically assessed through interviews by clinician researchers.  If there is a comparison group: Researchers will compare sham, traditional, and gamified treatment groups to see if they moderate symptoms of depression.

ICD-10 classifications

Depressive episodeOther depressive episodesRecurrent depressive disorderRecurrent depressive disorder, unspecifiedPost-schizophrenic depression

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06361095
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06361095 through Pure Global AI's free database. This Phase 1 trial is sponsored by University of Texas at Austin and is currently Not yet recruiting. The study focuses on Depression. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.